Risperdal Caused Teen Boy's Breast Growth, Jury Hears

Law360, Philadelphia (September 24, 2012, 7:12 PM EDT) -- A teenage boy grew breasts after years of ingesting Risperdal, an antipsychotic drug developed by a Johnson & Johnson subsidiary and illegally promoted for use in children despite studies showing the risk of side effects, the boy's attorney told a jury in a Philadelphia courtroom Monday.

In opening arguments in the Philadelphia Court of Common Pleas, an attorney for Andrew Bentley told the jurors that Ortho-McNeil-Janssen Pharmaceuticals Inc. engaged in a nationwide campaign to promote the drug for off-label use in children despite knowing that it...
To view the full article, register now.